Shentracon Chemicals Limited has announced the appointment of Ms. Rupali Purohit as Company Secretary and Compliance Officer, effective 03rd April, 2026. The appointment was approved by the Board of Directors and has been communicated to BSE Limited under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Board Meeting Outcome

The Board of Directors meeting was held on Friday, 03rd April, 2026, where the appointment was formally considered and approved. The company has filed the outcome with BSE Limited in compliance with regulatory requirements.

Key Appointment Details

Ms. Rupali Purohit has been designated as Key Managerial Personnel in her dual role as Company Secretary and Compliance Officer. The appointment strengthens the company's governance framework and compliance structure.

Professional Profile

According to the regulatory filing, Ms. Rupali Purohit brings extensive expertise in corporate governance and regulatory compliance. Her professional background encompasses several key areas critical to corporate oversight.

Regulatory Compliance

The appointment notification was filed pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Part A of Schedule III and SEBI Master Circular dated 30th January, 2026. The filing was signed by Amit Lalit Jain, Managing Director (DIN: 05263766).

Company Information

Shentracon Chemicals Limited operates from its corporate office at 1910, 19th Floor, 9 Business Bay, Khakhar Property, Behind Evershine Mall, Chincholi Bunder Malad (W), Mumbai, Maharashtra. The company is incorporated under CIN: L24299WB1993PLC059449 and trades on BSE Limited under scrip code 530757.

Shentracon Chemicals Limited has announced the approval of a new corporate office in Mumbai, marking a strategic move to enhance operational efficiency and administrative convenience. The decision was made during a board meeting held on March 27, 2026, with the company maintaining full regulatory compliance under SEBI guidelines.

Board Meeting Outcome

The board of directors convened to consider and approve the establishment of the new corporate office facility. The meeting was conducted efficiently under the leadership of Managing Director Amit Lalit Jain.

New Corporate Office Specifications

The board approved the establishment of the new corporate office with specific location and operational parameters designed for better operational efficiency and administrative convenience.

Operational Changes

The new Mumbai office will serve as a significant operational hub for Shentracon Chemicals Limited. The company will maintain its books of accounts at this new corporate office, indicating the strategic importance of this facility in the company's administrative structure.

Importantly, the company has clarified that there is no change in the registered office, ensuring continuity in its legal and regulatory framework while expanding its operational capabilities.

Regulatory Compliance

The announcement was made pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company formally communicated this development to BSE Limited, maintaining transparency with stakeholders and regulatory authorities.

The decision reflects Shentracon Chemicals Limited's strategic approach to operational expansion while maintaining full regulatory compliance and transparency with its stakeholders.